Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03937219 |
|---|---|
| Brief Title: | Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (COSMIC-313) |
| First Submitted : | May 2, 2019 |
| First Submitted that Met QC Criteria : | May 2, 2019 |
| First Posted : | May 3, 2019 |
| Last Update Submitted that Met QC Criteria : | February 8, 2021 |
| Last Update Posted : | February 10, 2021 |